Chromadex External Research Program News Today

NutraIngredients celebrated one decade of annual industry awards last night (May 15) with the winners of this year's competition announced at a VIP Party in Geneva.

ChromaDex CEO Rob Fried advocates for the formation of a new group "consisting of industry players endeavoring to be righteous in their practices."

Recent research suggests that taking supplements of NR, a form of vitamin B3, could lead to symptom improvement in people with Parkinson's disease.

LOS ANGELES--(BUSINESS WIRE)--Nov 30, 2023--

California-based ChromaDex Corp. has launched a high dose Tru Niagen product containing 1,000 mg of its Nicotinamide Riboside ingredient.

Celebrating a significant achievement in NAD+ research, these findings contribute to the mounting evidence indicating that NR may serve as a proactive safeguard against inflammatory cytokines in...

ChromaDex's Rebecca Idoine and Yusrah Ishtiaq delve into the science of nicotinamide riboside (NR), as well as the role of NAD+ in healthy aging.

NMN (Nicotinamide Mononucleotide) is a type of molecule that your body cells need to produce NAD (Nicotinamide Adenine Dinucleotide). NMN and NAD work together to boost your cells’ metabolic rate, reduce aging, provide energy, etc.

LOS ANGELES--(BUSINESS WIRE)--Aug 9, 2023--

The winners of the 2023 NutraIngredients-USA Awards will be revealed during a live broadcast on July 12. Our finalists excited to hear the results. You should be, too!